Post by Medical Device Network

GE HealthCare reported an impacted profit in Q1 2026 alongside a snipping of its full-year financial outlook, prompting the imaging specialist’s stock to drop by 13%. In Q1, the imaging specialist achieved revenue of around $5.1bn, corresponding to year-over-year (YoY) growth of 7.4%. Investors were mainly focused on GE HealthCare tempering its 2026 outlook. The company now expects 2026 earnings to fall in the $4.80-$5.00 range versus $4.95-$5.15 as outlined previously, with YoY growth now mooted to fall in the 4.6%-9% range, down from 7.9%-12.3% previously. #medtech #imaging #supplychain Read the full report below: https://lnkd.in/e8kqiCRK